Mindfulness-Based Cognitive Therapy via videoconference or self-help for preventing depression relapse
Official title: Effectiveness and Cost-Effectiveness of Mindfulness-Based Cognitive Therapy (MBCT) for the Prevention of Depression Relapse or Recurrence Using Videoconference in the Spanish National Health System
Run by Fundació Sant Joan de Déu · NCT06832605 · Data updated 2026-11-12
This trial tests whether mindfulness-based cognitive therapy delivered by videoconference or as a self-help program with light support can help adults with recurrent major depressive disorder stay well when added to usual care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 342 (estimated) |
| Sponsor | Fundació Sant Joan de Déu Academic / other |
| Locations | 5 sites (Elche, Alicante and 4 other locations) |
| Status | Recruiting |
| Started | June 10, 2026 |
| Main results expected | December 2027 |
| Study ends | September 2028 |
| Registry record updated | September 3, 2026 |
| Trial ID | NCT06832605 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults over 18 with recurrent major depressive disorder (at least two prior episodes) who have internet access and basic digital literacy.
✕Probably not a fit
Individuals with current severe depression, certain psychotic or substance use disorders, or those without access to technology may not benefit from these formats.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicentre randomized trial compares two delivery formats of MBCT to treatment as usual for adults with recurrent major depressive disorder, either in an acute episode or remission. Participants are allocated to group MBCT delivered via eight videoconference sessions, supported MBCT self-help with a manual and three low-intensity videoconference sessions, or TAU alone. The study measures clinical outcomes and costs at baseline, 6 months, and 12 months to assess effectiveness and potential moderators of response. It also explores mechanisms of change and predictors of who benefits most. Recruitment spans several centers in Spain, leveraging public health settings to evaluate real-world implementation.
Why it matters
Potential benefit: If successful, the trial could show scalable MBCT formats that reduce relapse risk and lower costs for recurrent depression.
How similar studies have gone: Prior MBCT research supports clinical efficacy, and this study adds Spain-specific, multicentre evidence and delivery via videoconference and self-help.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age over 18. * Diagnosis of recurrent major depressive disorder, with ≥ 2 previous major depressive episodes (MDD), either in an acute mild/moderate episode or in remission. * Internet access (via smartphone or personal computer). * Spanish literacy (spoken and written). Exclusion Criteria: * Current severe depressive episode (≥24 on the GRID-HAMD) * Current or past psychosis, bipolar 1 disorder, a history of schizophrenia, schizoaffective disorder, organic mental disorder, current severe substance abuse, organic brain damage, pervasive developmental delay, persistent antisocial behaviour, recent (in the past 6 months) self-injury requiring clinical management or therapy according to medical records and clinical judgment. * Formal concurrent structured psychotherapy during the intervention period. * No experience in the use of new technologies (smartphones or computers). * Having completed a mindfulness-based structured training and/or extensive meditation experience (i.e., previous participation in meditation retreats (≥1) or regular (≥ weekly) meditation practice) in the previous year, or intending to commence meditation retreats or meditation practice during the study.
Where it's running
-
Hospital General Universitario de Elche
Elche, Alicante, Spain Recruiting -
Parc de Salut Mar
Barcelona, Barcelona, Spain Recruiting -
Fundacio Centre Higiene Mental Nou Barris
Barcelona, Barcelona, Spain Recruiting -
Parc Sanitari Sant Joan de Déu (PSSJD)
Sant Boi de Llobregat, Barcelona, Spain Recruiting -
Hospital Universitario Miguel Servet
Zaragoza, Zaragoza, Spain Recruiting
Study contacts
- Principal investigator: Jesus Montero, PhD — Fundació Sant Joan de Déu
- Study coordinator: Jesus Montero, PhD
- Email: jesus.montero@sjd.es
- Phone: (34) 936 615 208 - 12733
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using light and negative ion therapy to prevent depression relapse
This study is testing whether light therapy and negative ion therapy can help people with recurrent depression stay well after stopping their antidepressants.
-
One session of high-frequency rTMS to help with severe arm weakness after stroke
This study tests whether a single high-frequency rTMS session on the affected arm can reveal more motor signals in the brain of stroke patients who have little or no hand movement.
-
Behavioral parent training with optional AI support for children with disruptive behaviors
This trial will test whether adding a 24/7 AI assistant to online group behavioral parent training helps parents manage children aged 5–12 with disruptive behaviors.
-
CuidAME: Spain's longitudinal registry for spinal muscular atrophy
This project collects long-term clinical and treatment data from children and adults with genetically confirmed 5q spinal muscular atrophy in Spain to track outcomes over time.
-
VR avatar therapy for psychosis: linking thinking, self-awareness, and social cognition
This project will test whether cognitive, metacognitive, and social-cognition factors relate to how well VR-based avatar therapy helps people with schizophrenia who have persistent auditory hallucinations.
-
How a mother's immunomodulatory drugs during pregnancy affect a newborn's immune development
This project tests whether babies born to mothers who took immunomodulatory drugs during pregnancy have measurable changes in their immune system.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.